An elevated expression of YBX3 in gastric cancer has been linked to advanced clinicopathological features, shorter survival time, and poor prognosis, which was consistent with the findings of Xiang and colleagues (Xiang et al. 2020). Here, YBX3 is linked to gastric cancer.